[YMAB] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
30-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 98.62%
YoY- 98.91%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 20,454 20,751 20,251 31,447 12,537 10,797 10,486 56.05%
PBT -7,560 -6,123 -6,390 1,157 -27,526 -41,131 -28,068 -58.25%
Tax 187 179 -1,293 1,558 1,509 1,186 373 -36.86%
NP -7,747 -6,302 -5,097 -401 -29,035 -42,317 -28,441 -57.94%
Tax Rate - - - -134.66% - - - -
Total Cost 28,201 27,053 25,348 31,848 41,572 53,114 38,927 -19.32%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -37.88 -30.37 -25.17 -1.28 -231.59 -391.93 -271.23 -73.04%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.18 -0.14 -0.12 -0.01 -0.66 -0.97 -0.65 -57.48%
EPS Diluted -0.18 -0.14 -0.12 -0.01 -0.66 -0.97 -0.65 -57.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.